BANCA MEDIOLANUM SPA (BMED.MI) Stock Overview
Europe - BIT:BMED - IT0004776628 - Common Stock
BMED.MI Key Statistics, Chart & Performance
The current stock price of BMED.MI is 16.96 EUR. In the past month the price decreased by -1.85%. In the past year, price increased by 47.74%.
BMED.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| HYQ.DE | HYPOPORT SE | 50.81 | 904.09M | ||
| MLEFA.PA | EDUFORM'ACTION | N/A | 7.46M |
Related stock screener links
About BMED.MI
Company Profile
Banca Mediolanum SpA engages in the provision of commercial banking services. The company is headquartered in Basiglio, Milano and currently employs 3,976 full-time employees. The company went IPO on 2015-12-30. The company operates thorough six segments: Italy Banking, Italy Asset Management, Italy Insurance, Italy Others, Spain and Germany. The Italy Banking segment provides a comprehensive range of customized solutions, which includes different kind of current accounts, payment instruments (credit, debit and prepaid cards), mortgages and loans, among others. The Italy Asset Management segment offers savings and investments through fund management activities. The Italy Insurance segment provides life and nonlife insurance policies and pension plans. The Italy Other segment comprises a series of financial items not directly attributable to the other lines of business and relating to events and businesses that extend across several areas. The segments Spain and Germany provide the same solutions under the Italian segments.
Company Info
BANCA MEDIOLANUM SPA
Via Ennio Doris, Palazzo Meucci
Basiglio MILANO IT
Employees: 3825
Phone: 390290451625
BANCA MEDIOLANUM SPA / BMED.MI FAQ
What is the stock price of BANCA MEDIOLANUM SPA today?
The current stock price of BMED.MI is 16.96 EUR. The price increased by 1.68% in the last trading session.
What is the ticker symbol for BANCA MEDIOLANUM SPA stock?
The exchange symbol of BANCA MEDIOLANUM SPA is BMED and it is listed on the Euronext Milan exchange.
On which exchange is BMED.MI stock listed?
BMED.MI stock is listed on the Euronext Milan exchange.
What is the price forecast or stock price prediction for BANCA MEDIOLANUM SPA stock?
17 analysts have analysed BMED.MI and the average price target is 17.81 EUR. This implies a price increase of 5.01% is expected in the next year compared to the current price of 16.96. Check the BANCA MEDIOLANUM SPA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BANCA MEDIOLANUM SPA worth?
BANCA MEDIOLANUM SPA (BMED.MI) has a market capitalization of 12.64B EUR. This makes BMED.MI a Large Cap stock.
How many employees does BANCA MEDIOLANUM SPA have?
BANCA MEDIOLANUM SPA (BMED.MI) currently has 3825 employees.
What are the support and resistance levels for BANCA MEDIOLANUM SPA (BMED.MI) stock?
BANCA MEDIOLANUM SPA (BMED.MI) has a support level at 16.95 and a resistance level at 17.51. Check the full technical report for a detailed analysis of BMED.MI support and resistance levels.
Is BANCA MEDIOLANUM SPA (BMED.MI) expected to grow?
The Revenue of BANCA MEDIOLANUM SPA (BMED.MI) is expected to decline by -8.14% in the next year. Check the estimates tab for more information on the BMED.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BANCA MEDIOLANUM SPA (BMED.MI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BMED.MI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BMED.MI, evaluating the profitability, health, valuation and growth aspects
- BANCA MEDIOLANUM SPA (BMED.MI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BANCA MEDIOLANUM SPA (BMED.MI) Sales and EPS estimates to see what analysts future expectations are.
- BANCA MEDIOLANUM SPA (BMED.MI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BANCA MEDIOLANUM SPA (BMED.MI) Insider and Institutional Ownership to learn about the owners and their transactions.
- BANCA MEDIOLANUM SPA (BMED.MI) Stock Chart to make your own analysis
- BANCA MEDIOLANUM SPA (BMED.MI) Latest news and press-releases to stay up to date.
Does BANCA MEDIOLANUM SPA (BMED.MI) stock pay dividends?
BANCA MEDIOLANUM SPA (BMED.MI) has a dividend yield of 5.96%. The yearly dividend amount is currently 0.79. Check the full fundamental report for a detailed analysis of BMED.MI dividend history, reliability and sustainability.
When does BANCA MEDIOLANUM SPA (BMED.MI) report earnings?
BANCA MEDIOLANUM SPA (BMED.MI) will report earnings on 2025-11-05.
What is the Price/Earnings (PE) ratio of BANCA MEDIOLANUM SPA (BMED.MI)?
The PE ratio for BANCA MEDIOLANUM SPA (BMED.MI) is 11.31. This is based on the reported non-GAAP earnings per share of 1.5 and the current share price of 16.96 EUR. Check the full fundamental report for a full analysis of the valuation metrics for BMED.MI.
BMED.MI Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to BMED.MI. When comparing the yearly performance of all stocks, BMED.MI is one of the better performing stocks in the market, outperforming 88.3% of all stocks.
BMED.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BMED.MI. There are concerns on the financial health of BMED.MI while its profitability can be described as average.
BMED.MI Financial Highlights
Over the last trailing twelve months BMED.MI reported a non-GAAP Earnings per Share(EPS) of 1.5. The EPS increased by 36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.36% | ||
| ROA | 1.88% | ||
| ROE | 38.66% | ||
| Debt/Equity | 0.99 |
BMED.MI Forecast & Estimates
17 analysts have analysed BMED.MI and the average price target is 17.81 EUR. This implies a price increase of 5.01% is expected in the next year compared to the current price of 16.96.
For the next year, analysts expect an EPS growth of -13.51% and a revenue growth -8.14% for BMED.MI